2011 - Transplantomics and Biomarkers in Transplantation
This page contains exclusive content for the member of the following sections: TTS. Log in to view.
Genomics and Personalized Medicine
4.2 - The Clinical Utility of Whole Genome Sequencing
Presenter: Rong, Chen, Stanford, CA, USA Authors: Rong Chen
The Clinical Utility of Whole Genome Sequencing
Rong Chen, Stanford University, Stanford, CA, USA
With over 30,000 human genomes estimated to be sequenced this year, now is the time to apply the whole genome sequencing technology into clinics. The utility of these genomes in a clinical setting remains controversial. Dr. Chen will present on his work on the first medical analysis of a patient presenting with a whole genome sequence, recently featured last year in the Lancet1, and will discuss how whole genome sequencing could revolutionize research and clinical care.
Suggested Reading Materials:
1. Ashley, E.A. et al. Clinical assessment incorporating a personal genome. Lancet 375, 1525-35 (2010).
By viewing the material on this site you understand and
The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
The material is solely for educational purposes for qualified
health care professionals.
The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
The information cannot be used as a substitute for professional
The information does not represent a standard of care.
No physician-patient relationship is being established.